Cargando…
Efficacy and Safety of Steroid Therapy for Posttransplant Hyperbilirubinemia Caused by Early Allograft Dysfunction: A Randomized Controlled Trial
BACKGROUND: Hyperbilirubinemia is a common event that occurs after liver transplantation. Hyperbilirubinemia is usually caused by early allograft dysfunction. Glucocorticoid is widely used for immunosuppression, but few studies have analyzed the effects of steroid therapy on posttransplantation hype...
Autores principales: | Yang, Jie, Yang, Lei, Wu, Linwei, Zhao, Qiang, Chen, Maogen, He, Xiaoshun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429985/ https://www.ncbi.nlm.nih.gov/pubmed/30870403 http://dx.doi.org/10.12659/MSM.915128 |
Ejemplares similares
-
MicroRNA-146b-5p Identified in Porcine Liver Donation Model is Associated with Early Allograft Dysfunction in Human Liver Transplantation
por: Li, Cheukfai, et al.
Publicado: (2017) -
A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation
por: Huang, Changjun, et al.
Publicado: (2021) -
Urinary Calprotectin and Posttransplant Renal Allograft Injury
por: Tepel, Martin, et al.
Publicado: (2014) -
Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma
por: Patel, Krina K., et al.
Publicado: (2022) -
Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus
por: Gupta, Suruchi, et al.
Publicado: (2018)